我國獸藥行業發展預測以及獸藥研發思路(下)

jinnyjinny

<TABLE class=seyle4 cellSpacing=0 cellPadding=0 width="100%" border=0>
<TBODY>
<TR>
<TD id=content9 vAlign=center><STRONG style="FONT-SIZE: 14px">我國獸藥行業發展預測以及獸藥研發思路(下)</STRONG></TD></TR>
<TR>
<TD>
<DIV align=right><SPAN class=textbox-label>[ 2008-8-18 10:20:00 | By: <SPAN class=style3>徐陽</SPAN> ]</SPAN></DIV></TD></TR></TBODY></TABLE>
<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0>
<TBODY>
<TR>
<TD height=3>&nbsp;</TD></TR></TBODY></TABLE>
<TABLE style="TABLE-LAYOUT: fixed" cellSpacing=0 cellPadding=0 width="100%" align=center border=0>
<TBODY>
<TR>
<TD><SPAN class=oblog_text>
<DIV><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體, MS Song; mso-font-kerning: 1.0pt; mso-bidi-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA; mso-fareast-font-family: 宋體">&nbsp;4</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-font-kerning: 1.0pt; mso-bidi-font-family: 'Times New Roman'; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA">獸藥研發趨勢</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體, MS Song; mso-font-kerning: 1.0pt; mso-bidi-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA; mso-fareast-font-family: 宋體"> <BR></SPAN></DIV>
<DIV><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體, MS Song; mso-font-kerning: 1.0pt; mso-bidi-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA; mso-fareast-font-family: 宋體"></SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-font-kerning: 1.0pt; mso-bidi-font-family: 'Times New Roman'; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA">新獸藥的研發將受到空前的重視，現在大部分獸藥生產廠家的偽獸藥開發模式，將隨著國家的整頓和嚴查，很快會失去市場。約</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體, MS Song; mso-font-kerning: 1.0pt; mso-bidi-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA; mso-fareast-font-family: 宋體">2009~2010</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-font-kerning: 1.0pt; mso-bidi-font-family: 'Times New Roman'; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA">年即可形成。</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-font-kerning: 1.0pt; mso-bidi-font-family: 'Times New Roman'; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA">下一步的獸藥研發模式將與人藥現在的研發模式相仿。但由于大部分廠家的研發人員水平較低，沒能力獨立完成新藥項目的研發，因此這些廠家的研發部門可能被取消，轉而開展與其他廠家或科研單位聯合研發的模式。將來的新藥研發模式可能有以下幾種：</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體, MS Song; mso-font-kerning: 1.0pt; mso-bidi-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA; mso-fareast-font-family: 宋體">&nbsp; <BR></SPAN></DIV>
<DIV><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體, MS Song; mso-font-kerning: 1.0pt; mso-bidi-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA; mso-fareast-font-family: 宋體"></SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-font-kerning: 1.0pt; mso-bidi-font-family: 'Times New Roman'; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA">技術力量較強的廠家可能獨立完成某些項目的研發；多個廠家聯合開展研發，聯合申報；廠家與科研單位聯合研發；廠家出資購買科研單位的研究成果。</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體, MS Song; mso-font-kerning: 1.0pt; mso-bidi-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA; mso-fareast-font-family: 宋體"> <BR></SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-font-kerning: 1.0pt; mso-bidi-font-family: 'Times New Roman'; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA"></SPAN></DIV>
<DIV><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-font-kerning: 1.0pt; mso-bidi-font-family: 'Times New Roman'; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA">建議進行研發集中化，這樣優勢可以從升標過程看到優點。</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10.5pt; FONT-FAMILY: ??; mso-font-kerning: 1.0pt; mso-bidi-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA; mso-fareast-font-family: 宋體"></DIV></SPAN>
<P><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">5</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">行業趨勢推算</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR>&nbsp;</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">　</SPAN></SPAN></P>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt"></SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">5.1&nbsp;2008</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">年：主要是嚴查禁藥；規范獸藥包裝說明，法定標準樣稿，出臺規范包裝說明文件；</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">&nbsp;</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">出臺獸藥</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">GSP</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">規范及相關文件，職業獸醫師考試初步定型。</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR>&nbsp;</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">　</SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt"></SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">5.2&nbsp;2009</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">年：主要是禁用藥物基本被禁止；規范包裝說明使用期限到期，企業規范包裝完成；獸藥</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">GSP</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">認證工作初步開始。</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR>&nbsp;</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">　</SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt"></SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">5.3&nbsp;2010</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">年：獸藥</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">GSP</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">認證工作進入高潮；社會養殖散戶改造初步開始，著手制定藥物殘留和檢驗檢疫制度；開始嚴查食品加工業產品禁用藥物，打通禁藥限制鏈條的各個環節，使禁藥檢查系統化，制度化；社會規模化養殖場初步興建，部分社會雞頭和獸藥經銷商開始入主養殖場。</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR>&nbsp;</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">　</SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt"></SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">5.4&nbsp;2011</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">年：生產企業基本按照法定標準組織生產，同質化現象嚴重，惡性競爭激烈，一批生產企業經營不善，倒閉或被兼并；獸藥</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">GSP</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">認證工作基本完成，醫藥開始分離，職業獸醫師開始推廣；</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">&nbsp;</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">社會養殖散戶改造繼續深入，各項管理制度基本開始正常運行；一部分養殖水平不高的社會養殖散戶開始受雇于規模化養殖場，轉變為養殖工人；政府出臺獸藥殘留、疫病監控等相關文件，將養殖散戶的改造引向深化；政府開始發揮綜合主導管理作用，整個管理系統框架初步構建。</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">&nbsp; <BR>&nbsp;</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">　</SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt"></SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">&nbsp;5.5&nbsp;2012~2015</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">年：社會養殖散戶逐步減少，規?；B殖場和一條龍自養穩步擴大，養殖散戶逐步轉變為規?；B殖廠的養殖工人；</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">&nbsp;</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">生產企業注重研發創新，開展各種聯合研發模式。其銷售模式逐步發生改變，開始主攻一條龍自養和社會規?；B殖場；獸藥</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">GSP</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">經銷商開始逐步萎縮，部分經銷商將向上游生產企業或下游規模化養殖場尋找出路，轉變為生產企業主或規?；B殖場負責人。</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR></SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"></SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">5.6&nbsp;2016~2020</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">年：生產企業定位基本完成，行業基本趨于穩定，開始形成各自的特色；獸藥經銷商大部分轉行或搞多元經營，只有小部分經銷商開始服務于新興的特色養殖和各種寵物行業；大部分養殖散戶轉變為規模化養殖場的養殖工人，小部分轉為特色養殖，原來的社會散養戶基本消失；社會規模化養殖形成規模，并開始優化重組，有的被一條龍集團并購，或者多個養殖場合并為一個新集團。</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR></SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"></SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">6</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">企業研發的路在何方</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR></SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"></SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">6.1</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">離行業真正規范還有近</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">10</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">年的路走，那么獸藥研發必將延續現有模式逐步改善。</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR></SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"></SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">6.2</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">真正的研發是高風險的行業，新獸藥的研究與開發是一項耗資大、周期長、技術要求高、風險大的系統工程。國外大約需要幾十年，并需要拿出相當多的企業利潤作為研發經費。與國外相比，我國的獸藥研發還處于一個初級階段，未來國內獸藥研發的趨勢是兩大方向：重點發展原料藥，尤其是發展動物專用的原料藥；獸用原料藥的研究開發仍以抗菌藥物和抗寄生蟲藥物為主導方向。</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR>&nbsp;</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">在藥物添加劑方面，無殘留、無交叉耐藥性的抗菌促生長劑、中草藥添加劑、活菌制劑和酶制劑是一大發展方向。</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR></SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"></SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">7</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">研發的思路</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR></SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"></SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">市場決定一切，企業的研發和科研機構研發的不同；沒有多少人愿意與企業家共同推動社會物質文明的進步與發展，實實在在的面對市場，解決社會和企業關心的問題；企業需要什么樣的產品決定于市場而不是在產品；復發制劑和中藥制劑將是突破點。</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR></SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"></SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">7.1</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">復方制劑的研發思路</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR></SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt"></SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt"></SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">解決臨床疾病，降低臨床用藥費用和節省用藥。藥效在一定意義上決定獸藥研發的生命力，因此必須以臨床到藥物這個過程為出發點。</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR></SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"></SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">7.2</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">臨床疾病的治療思路</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR></SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"></SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">7.2.1</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">常規思路</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR></SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"></SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">癥狀－剖檢－屬于何種疾病－治療方法和措施。</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR></SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"></SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">反思常規思路的科學性？</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR></SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt"></SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt"></SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">通病異治，異病同治的思想精髓就是從損傷到治療，需要臨床辯證來區分疾病。</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR></SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"></SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">7.2.2</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">藥理人員的思路</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR>&nbsp;</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">癥狀－剖見－推斷損傷模型－根據生理和病理－治療方案形成－形成復發制劑的基礎。</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR></SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt"></SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt"></SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">7.3</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">尋找新藥的途徑和方法</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR></SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"></SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">7.3.1</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">途徑：</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR></SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt"></SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">從市場上去找需求，做好充足的市場調研；從文獻中檢索熱點領域，讓市場來檢驗；從藥物專利即將期滿的品種中去尋找。</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR></SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"></SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">7.3.2</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">方法：</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR></SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"></SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">7.3.2.1</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">加強藥劑學的基礎研究，大力開發獸藥新制劑。我國獸藥原料與制劑的比例約為</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">1</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">︰</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">2</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">，而國外為</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">1</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">︰</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">5</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">。據資料說明，開發一個藥物新劑型一般只需</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">100</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">～</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">300</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">萬美元（僅為創制新藥費用的</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">1%</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">），將一個控釋制劑推上市場平均只花</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">3</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">～</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">5</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">年（為創新藥的</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">1/3</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">～</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">1/2</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">），并且對于用高技術研制的新劑型美國仍列為新化學實體類，享受同等的專利保護期，這要求我國醫藥和獸藥行業從總體戰略上重視制劑的研究與開發。</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">&nbsp; <BR></SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"></SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">7.3.2.2</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">中藥復方以古方、驗方為主，研制要符合中醫藥學辯證論治、理法方藥、方劑的君臣佐使等理論；西醫復方尤其要注意組方依據充分，在藥理學理論上要站得住腳，對適應癥的病理、復方中藥物的作用及機理要有合理的解釋；在藥劑學上也要有配伍正確性的依據。復方的藥味數不宜太多，否則會使控制因素復雜化，難以評價。一般以</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">2</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">～</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">3</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">味藥為宜，</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">4</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">味以上則極難通過。</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">&nbsp; <BR></SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"></SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">7.3.2.3</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">大多數品種是歷代醫家反復篩選、留傳千載的經驗結晶。應用現代科學手段對中草藥深入研究，是我國創新藥物或發現新用途最有希望的突破口。特別是在知識產權保護日益嚴密的今天，在這一領域加強開發研究已成為必然趨勢。近年來，青蒿琥酯、桔皮油的開發成功是突出的例證。此外，各地還有大量新的中藥復方制劑用于獸醫臨床。</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR></SPAN></SPAN></DIV>
<DIV class=MsoNormal style="MARGIN: 0cm 0cm 0pt"><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"></SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">7.4</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">中藥研發的問題</SPAN></SPAN><SPAN style="FONT-SIZE: 10pt"><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt"><BR>&nbsp;</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">由于藥材生產尚未達到基地化、規模化、標準化</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">,</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">造成藥材質量相差懸殊</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">,</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">而不穩定的藥材難以生產出質量穩定、合格優質的產品。另一方面</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">,</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">國內中獸藥生產單位由于硬件</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">(</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">如大型儀器高效液相色譜儀等</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">)</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">和軟件</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">(</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">如人才、技術等</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">)</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">條件的不足</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">,</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">使得中獸藥質量標準在研究時</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">,</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">對其制定粗糙</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">;</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">生產上市時</SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; mso-bidi-font-size: 10.5pt">,</SPAN><SPAN style="FONT-SIZE: 10pt; FONT-FAMILY: 宋體; mso-hansi-font-family: ??; mso-ascii-font-family: ??; mso-bidi-font-size: 10.5pt">對其控制不力。(轉載網絡)</SPAN></SPAN><SPAN lang=EN-US style="FONT-SIZE: 10pt; mso-bidi-font-size: 10.5pt"><?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></SPAN></DIV></SPAN></TD></TR></TBODY></TABLE>
<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0>
<TBODY>
<TR>
<TD height=3>&nbsp;</TD></TR></TBODY></TABLE>